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method of lesion segmentation. Number of BML lesions correlates less
well than WORMS score with their volume. There is a ﬁxed error due to
the nature of the WORMS method which biases the results in favour of
higher WORMS measurements.
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SENSITIVITY OF CEST MRI OF HUMAN KNEE CARTILAGE IN VIVO
AT 3T AND 7T
M. Haris, A. Singh, V. Kassey, K. Cai, D. Reddy, H. Hariharan, R. Reddy.
Univ. of Pennsylvania, Philadelphia, PA, USA
Purpose: To evaluate the sensitivity of chemical-exchange-saturation
transfer imaging of glycosaminoglycans (GAG) (gagCEST) on human knee
cartilage in vivo at 3T and 7T.
Methods: The study was conducted under an approved Institutional
Review Board protocol of the University of Pennsylvania. With an
informed consent CEST imaging was performed on the knees of six
healthy human volunteers using 18-cm diameter, eight-channel transmit-
receive phased-array (PA) knee coil on Siemens 3T (Magnetom Tim
Trio, Siemens Medical Solutions, Malvern, PA) and 7T MR scanner
(Siemens Medical Solutions, Malvern, PA). A new pulse sequence was
designed to use a frequency selective saturation pulse train followed
by a segmented RF spoiled gradient echo (GRE) readout sequence. The
sequence parameters were: slice thickness = 5mm, GRE ﬂip angle =10°,
GRE readout TR=5.6ms, TE =2.7ms, ﬁeld of view = 140×140mm2, matrix
size = 128×128, and one saturation pulse and 128 segments acquired
every 10 sec to enable full T1 recovery. Multiple CEST images were
collected using a saturation pulse with average B1rms of 31 (0.7mT), 62
(1.4mT), 93 (2.1mT) and 124Hz (2.8mT) and saturation offsets relative to
water ranging from −3.0 to +3ppm in steps of 0.1ppm.The total scan time
was ~30 minutes. To alleviate B0 and B1 inhomogeneity contribution
from CEST effect, B0 and B1 maps from the same imaging slices were
also obtained.
Fig. 1. 3 T.
Fig. 2. 3 T.
Fig. 3. 7 T.
Results: Without any corrections for B0 inhomogeneity a clear shift
(~0.5–0.6ppm) in the Z-spectra was observed in the human knee
cartilage. This shift in the human data is removed after correcting for the
B0 inhomogeneity. Without any correction for B0 large gagCEST effect
(20–25%) was observed on cartilage (Figures 1, 2). After B0 correction,
with the imaging and saturation pulse parameters used, the calculated
average gagCEST from cartilage was ~1% at 3T (Figures 1, 2) and 7.4±0.3%
at 7T (Figure 3). The effect of B1 inhomogeneity was minor in the current
study.
Conclusion: Because of the uneven geometry of human knee, despite
extensive shimming of B0 ﬁeld, there is a substantial B0 ﬁeld variation
in knee cartilage. Without correction for the B0 ﬁeld inhomogeneity,
spuriously large (20–30%) gagCEST effect is observed in knee cartilage in
vivo. Correction of the B0 inhomogeneity has shown that there is only
a very small (~1%) gagCEST observable in cartilage in vivo at 3T and a
signiﬁcantly larger gagCEST of ~7% at 7T. Since GAG loss from cartilage
is expected to result in further reduction in gagCEST, this method is not
expected to lead to accurate quantiﬁcation of GAG content in healthy as
well as in degenerated cartilage at 3T. However, given the magnitude of
gagCEST measured at high ﬁelds such as 7T, this technique holds promise
for studying cartilage degeneration at 7T and higher ﬁelds.
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THE MINIMAL CLINICALLY IMPORTANT DIFFERENCE (MCID) IN
CARTILAGE VOLUME AND THICKNESS CHANGE IN PERSONS WITH
KNEE OSTEOARTHRITIS
E. Losina1, J. Collins1, D.J. Hunter2, F. Eckstein3, M.C. Nevitt4, S. Cotofana3,
C.K. Kwoh5, J.N. Katz1. 1Brigham and Women’s Hosp., Boston, MA, USA;
2Univesrity of Sydney, Sydney, Australia; 3Paracelsus Private Med. Univ.,
Salzburg, Austria; 4Univ. of California, San Francisco, CA, USA; 5Univ. of
Pittsburgh and Pittsburgh VAHS, Pittsburgh, PA, USA
Purpose: Investigators use quantitative cartilage morphometry to
document longitudinal changes in osteoarthritic knees. With rapid
evolution in the capacity of MRI to detect small changes, clinicians
confront the question of how much change is clinically meaningful. We
sought to establish the minimal clinically important difference in MRI-
based longitudinal cartilage evaluation of persons with knee OA.
Methods: We used data from one knee per person of 429 participants of
the Progression Cohort of the Osteoarthritis Initiative (OAI), deﬁned by
the presence of frequent symptoms and deﬁnite radiographic knee OA,
who had baseline and 24 month quantitative MRI assessment. Manual
tracing of the total subchondral bone area of the medial/lateral tibia
(MT/LT) and central (weight-bearing) medial/lateral femoral condyle
(cMF/cLF) was performed by Chondrometrics GmbH (Ainring, Germany)
and publicly released. We considered the mean cartilage thickness
over the entire subchondral bone area with (ThCtAB) and without
(ThCcAB) denuded areas. Results for the medial and lateral femorotibial
compartments were obtained by summing values of MT + cMF and
LT +cLF respectively. We deﬁned the MCID in cartilage volume and
thickness changes from baseline to 24 months using the indirect anchor
method, in which changes exceeding a previously established minimum
or “anchor” are considered clinically important. The anchor was deﬁned
by worsening by at least 13 points on WOMAC Function scale (Angst,
2001). MRI-based morphology measures were compared between knees
that showed discrimination between those who did and who did not
achieve the MCID at a 0.05 signiﬁcance level.
Results: Among 429 knees, 43% had K-L grade 2 and 54% K-L grade 3.
68% had OA in medial compartment. 11% worsened by at least 13 points
in WOMAC Function score over 24 months. A limited set of MRI-based
cartilage morphology measures discriminated (at p =0.05) between those
who did and those who did not worsen in WOMAC Function by the
MCID. These included cartilage volume, cartilage thickness (including and
excluding denuded area) as well as the area of subchondral bone covered
by cartilage – all measured in the central (weight-bearing) medial femur.
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The other measures that discriminated between those reaching the MCID
and those who did not were cartilage volume and thickness of total
medial femorotibial compartment. The Figure illustrates SRM thresholds
corresponding to the MCID in cartilage morphology measurements,
where the differences between those who achieve worsening deﬁned
by MCID were statistically signiﬁcantly different (p< 0.05) from those
who did not. MCID for cartilage volume loss over the central medial
femoral and medial femorotibial compartment was estimated at 6.6%
and 6.7% respectively. MCID for cartilage thickness loss in the central
medial femoral compartment was estimated at 6.3% including denuded
area and 3.3% excluding it. These 3–7% losses correspond to SRMs (mean
change / SD change) of approximately 0.5 to 0.65 (Figure).
Figure: Changes over 24 months in cartilage morphology stratiﬁed by
achieving MCID in functional worsening.
Conclusions: These data offer clinically meaningful thresholds in
quantitative cartilage morphology changes measured by MRI. Planning
clinical trials based on changes in cartilage volume and thickness in the
central medial femur may lead to the most efﬁcient design in terms of
sample size.
386
MAGNETIC RESONANCE IMAGING: CARTILAGE DEFECT ASSESSMENT IS
LESS SENSITIVE THAN THE QUANTIFICATION OF CARTILAGE VOLUME
LOSS IN A KNEE OSTEOARTHRITIS DMOAD TRIAL
L.M. Wildi1, J. Martel-Pelletier1, F. Abram2, T. Moser3, J-P. Raynauld1,
J-P. Pelletier1. 1Osteoarthritis Res. Unit, Univ. of Montreal Hosp. Res. Ctr.
(CRCHUM), Montreal, QC, Canada; 2ArthroVision Inc, Montreal, QC, Canada;
3Dept. of Radiology, Univ. of Montreal Hosp. Ctr. (CHUM), Notre-Dame
Hosp., Montreal, QC, Canada
Purpose: Magnetic resonance imaging (MRI) has become the tool of
choice for the assessment of knee osteoarthritis (OA) structural changes
and disease severity in cross-sectional and longitudinal studies. Amongst
methods currently used for cartilage evaluation are semiquantitative
scoring systems and quantitative volumetry. For the former method, MRI
sequences vary greatly among studies and are subject to debate. This
study aimed to evaluate both the impact of the choice of MRI sequences
on the cartilage defect assessment and the sensitivity to change of
semiquantitative and quantitative methods.
Methods: Post-hoc analysis of the MR image database of two recent
clinical trials in knee OA (Cohort 1, n = 24 and Cohort 2, n = 143[1]) was
performed. Standard inclusion and exclusion criteria were employed. For
both cohorts, a gradient echo fat suppressed T1-weighted (T1) sequence
was used, and patients of Cohort 1 underwent an additional fast spin
echo fat suppressed proton density (PD) sequence. MR images were
performed at baseline and 2 years. Cohort 2 included patients from
a trial examining the chondroprotective effect of licofelone (200mg
bid) versus naproxen (500mg bid)[1]. Cohort 1 was used to assess
the impact of the two MRI sequences on cartilage defect scores, and
Cohort 2 to evaluate, for the two methods, the sensitivity to change and
detectability of the treatment effect. The cartilage defects and cartilage
volume were evaluated using the semiquantitative WORMS[2] method
and the proprietary software Cartiscope™[3], respectively, on the same
patient. Evaluation was performed for the global knee (GK) as well as
medial (MC) and lateral (LC) compartments and subregions. Statistical
analysis for Cohort 1 included the Wilcoxon signed rank test and for
Cohort 2 the Student’s t-test and the standardized response mean (SRM)
of change.
Results: In Cohort 1, the cartilage defect assessment provided consistent
and signiﬁcantly higher scores in PD than in T1 sequences both at
baseline and 2 years (p < 0.001). Interestingly, in all regions studied,
the change from baseline to 2 years was not signiﬁcantly different
(p≥0.377). In Cohort 2, the SRM for the cartilage defects and volume loss
were respectively 0.365 and 2.000 for GK; 0.293, 1.473 MC; and 0.252,
1.165 LC, indicating that the quantitative cartilage volume evaluation
demonstrated greater sensitivity to change. With regard to treatment
effect, data revealed no signiﬁcant difference in cartilage defect score
change over 2 years between the two treatment groups, while the
change in cartilage volume loss demonstrated a signiﬁcant difference
in GK (p =0.009) and LC (p =0.026) as previously published[1].
Conclusions: OA cartilage defects assessed with the PD MRI sequence
showed a higher score than T1 in cross-sectional evaluation. However,
neither of the MRI sequences demonstrated superiority in assessing
cartilage defect change over time; therefore both are valuable for
evaluating cartilage lesions cross-sectionally. With regard to clinical
DMOAD trials, quantitative assessment of cartilage volume loss is more
sensitive than the semiquantitative method for the evaluation of changes
in OA cartilage lesions over time.
Reference(s)
[1] Raynauld JP, et al. Ann Rheum Dis 2009;68:938–47.
[2] Peterfy CG, et al. Osteoarthritis Cartilage 2004;12:177–90.
[3] Raynauld JP, et al. Osteoarthritis Cartilage 2003;11:351–60.
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CARTILAGE T2 RELAXATION TIME MEASUREMENTS AT THE KNEE ARE
ASSOCIATED WITH METABOLIC SYNDROME AND LIFESTYLE FACTORS
P.M. Jungmann1, M.S. Kraus1, H. Alizai1, L. Nardo1, T. Baum2, M.C. Nevitt3,
J. Lynch3, C.E. McCulloch3, T.M. Link1. 1Musculoskeletal and Quantitative
Imaging Res., Dept. of Radiology and BioMed. Imaging, Univ. of California,
San Francisco, CA, USA; 2Dept. of Radiology, Technical Univ. of Munich,
Munich, Germany; 3Dept. of Epidemiology and Biostatistics, Univ. of
California, San Francisco, CA, USA
Purpose: Prevention of osteoarthritis (OA) may be achieved through
modiﬁcation of life style parameters; among these obesity and metabolic
syndrome are of particular interest. T2 relaxation time measurements
of hyaline cartilage provide information on cartilage water content and
collagen degradation; these measurements provide an early assessment
of cartilage degeneration, before there is structural cartilage loss. The
aim of this study was to study how individual facets of the metabolic
syndrome are associated with cartilage degenerative changes measured
with T2 values at the knee using 3T MR images in middle-aged
individuals from the Osteoarthritis Initiative (OAI) incidence cohort
without radiographic osteoarthritis.
Methods: MR images of right knees of 405, 45–60 year old individuals
(n = 205 male, n = 200 female) with risk factors for osteoarthritis but
without knee pain and without radiographic ﬁndings for osteoarthritis
(K/L score 0 and 1) were analyzed. Cartilage segmentation was performed
in ﬁve compartments (patella, medial tibia, lateral tibia, medial femoral
condyle, lateral femoral condyle) and T2 relaxation time maps were
generated. Factors analyzed included diabetes mellitus type II (DM, self-
reported), body mass index (BMI), abdominal circumference, diastolic
and systolic blood pressure, as well as fat content of nutrition.
Additionally nicotine consumption and alcohol consumption were
evaluated. Statistical signiﬁcance was determined by using analysis
of variance and corrected for differences in age, gender and OA risk
factors other than BMI (eg, history of knee injury, family history of
knee replacement, Herbeden nodes in hands) in a multivariate linear
regression model.
Results: As shown in Figure 1 signiﬁcantly increased cartilage T2 values
were found in individuals presenting with DM (P=0.0122) and systolic
hypertension (P = 0.0464), but not for high diastolic blood pressure.
BMI and abdominal circumference showed the strongest effect on
T2 changes, which were most prominent in the medial compartment
(P < 0.0001; Figure 2). While general alcohol consumption had no effect,
increased beer consumption showed a non-signiﬁcant trend (P = 0.0602).
Neither nicotine consumption nor pack years of cigarette smoking were
